Off the wire
China, S. Korea, Japan should remove obstacles, build up consensus to develop ties: Wang Yi  • Afghan forces kill 7 militants in northern Kunduz, clash continues  • Myanmar's USDP new chairman vows to win 2020 general election  • China ready to offer help to quake-hit Italy  • China continues working with New Zealand on economic fugitive  • UNFPA provides Bangladesh health centers reproductive health kits  • 2nd LD: Damascus condemns Turkish military intervention inside Syria  • China eyes reform, innovation to drive less-developed areas  • Mongolian gov't urges hard work in harvesting before colder weather  • China, S. Korea, Japan should develop ties in spirit of taking history as mirror, look forward to future: Chinese FM  
You are here:   Home

Aussie scientist discovers a cheaper, less painless fertility treatment alternative

Xinhua, August 24, 2016 Adjust font size:

Scientists in Australia and Belgium have developed an enhanced method of in-vitro maturation (IVM) that may provide a more affordable and less painless option than IVF to the thousands of couples seeking fertility treatment in the near future.

Researchers at University of New South Wales, University of Adelaide and Free University of Brussels said on Wednesday that they had developed a new growth factor called cumulin, which allows eggs to be retrieved earlier than in IVF, and matured outside the womb.

At present, the in-vitro fertilization (IVF) is a more common fertility treatment, in which women are given hormones to stimulate egg growth before they are removed from the ovaries and fertilized elsewhere.

UNSW Associate Professor Robert Gilchrist who led the project said new approach might help eliminate drugs from infertility treatment altogether.

"The aim of our research has been to restore, as far as possible, the natural processes that occur during egg maturation,"he said in a statement on Wednesday.

"We have demonstrated that it is possible to improve egg quality and embryo yield with next to no drugs, using potent growth factors produced by the egg."

The innovative technique, which is awaiting U.S. Food and Drug Administration approval, has been 15 years in the making.

The research, published in the Journal of Biological Chemistry, showed a doubling of embryos when performed on pig eggs.

Pre-clinical trials on human eggs resulted in a 50 percent boost in the number of embryos compared to regular IVM, with minimal use of drugs.

"We initially did the experiments using pig eggs. And there we got an improvement in egg quality and a doubling in embryo yield," Gilchrist said.

"We could have a promising technology in the very near future." Enditem